Our approach to CBD content creation

321CBD: a mission of information and education assumed

321CBD is not just a reference online store for CBD products in France. Right from the start, we wanted to couple our activity with an educational effort, bringing sourced, reliable and relevant information to our customers.

Although consumed regularly or occasionally by over 7 million French people, CBD is still a novelty, even a mystery for many. It has to be said that its legalization is very recent (end of 2020). Its consumable nature reinforces the need for transparency and clarity on the information we disseminate.

321CBD is an online store, with all that this implies in terms of logistics, supply chain management and so on. But it's also an editorial team specialized in health and wellness themes, supported by experienced content creators trained in the specifics of cannabinoids. Our objective is clear: to inform our customers, giving them the keys to understanding our products, their use and their effects. We want to help them understand what CBD is... but also what it isn't, far from the allegations and other untruths that are unfortunately not uncommon in the CBD microcosm. With this in mind, we've erected the content we produce as an essential component of our online store.

The integrity of the content we make available to you is a priority for us, and not a sales pitch. In concrete terms, we take care to offer you information that is fair, accurate and constantly updated. Choosing, purchasing and using CBD-based products can be complex processes, and we're keen to support our customers every step of the way in an ethical and responsible way, whether through the content posted on our blog, the product sheets made available or exchanges by telephone and Live Chat.

With this page dedicated to our approach to content creation, we want to make this commitment visible to everyone, and explain how we do everything we can to produce content worthy of your trust.

The four pillars of our CBD editorial policy

1. What CBD is, and what it isn't

Every blog post and product description we write is based on scientific truths about cannabidiol and the cannabinoids in the hemp plant. These cross-cutting aspects are the common thread running through all our content:

• CBD in its "mainstream" form is not a medicine and, as such, can under no circumstances be recommended or advised in the management of any pathology;
• We are an online store dedicated to over-the-counter CBD products. We are not qualified to give medical or therapeutic advice;
• Topics associated with CBD scientific research are discussed from an informational angle, not as sales pitches to sell CBD;
• There is no "universal dose" of CBD. Consumption modalities vary according to the individual: weight, age, goals, the body's sensitivity to cannabinoids, etc.
• CBD is not a miracle molecule, and is never presented as such in our content. Instead, science has proven CBD's many benefits, including its soothing and relaxing properties, anti-inflammatory effects, antioxidant action and pain-relieving virtues;
• In France, and in many European Union countries, only CBD and hemp products with less than 0.3% THC are authorized for sale.

2. Rigor, without compromise

Every piece of content we produce at 321CBD is the result of a rigorous, tried-and-tested process. The choice of themes to tackle is based on several sources:

• The monitoring that our team carries out on a daily basis, whether on news sites or social networks;
• The scientific watch, which allows us to stay on top of all the latest news on the effects of CBD;
• Our exchanges with our customers by phone, email and via Live Chat;
• Our customers' comments on product sheets.

Once we have a clear idea of the questions to be addressed, we enter the research phase. We don't limit ourselves to a simple online search: we consult directly the relevant scientific and medical studies, published in peer-reviewed journals. We're in touch with health professionals who work with CBD, and we stay up to date with the latest reports and recommendations from health organizations, including ANSM, the Ministry of Health, the Academy of Medicine and the WHO.

The information we collect is not simply recopied or reformulated. We analyze every piece of data, every study, every recommendation to extract the essential information and present it in a way that is accessible to our customers. We are careful to cite our sources and explain how we arrived at our conclusions. Also, we don't hesitate to deliver a critical look at the information disseminated.

For example, 321CBD advocates a tightening of the legislative paradigm on cannabinoids. Insofar as new cannabinoids are discovered every decade in the hemp plant (of which there are over a hundred), we believe the logic should be as follows: all unauthorized cannabinoids must be banned, which is not the case today. In fact, unbanned cannabinoids are authorized for sale, before the legislator realizes their harmfulness and bans them several months or even years after their arrival on the market.

After editing, each piece of content is proofread by several members of our team to ensure accuracy and clarity. Any inaccuracies or ambiguities are corrected before publication.

After editing, each piece of content is proofread by several members of our team to ensure accuracy and clarity.

3. Ethics, the cement of our mutual trust

At 321CBD, we have a precise and operational definition of ethics in our industry.

Firstly, and it goes without saying, ethics begins with strict compliance with current legislation, with a non-negotiable precautionary principle. In concrete terms, we systematically check that all our products contain less than 0.3% THC, in compliance with French law. We clearly indicate this information on our product descriptions, so that our customers know exactly what they are buying and can consume their product with complete peace of mind.

Secondly, ethics for us means unflinching honesty about the real effects of CBD. We avoid any wording that might suggest CBD is some kind of panacea, some kind of miracle molecule. We highlight the benefits of CBD that research has demonstrated, while reminding us that each individual may react differently to its consumption and that its use should always be in line with dosage recommendations.

Thirdly, we are committed to providing clear, understandable information about our products. This means avoiding unnecessary technical jargon, clearly explaining what each product contains and how to use it, and answering our customers' questions in an open and transparent manner.

Finally, we are committed to providing clear and understandable information about our products.

Finally, we don't make promises we can't keep. If a product is out of stock, we say so. If a product has potential side effects, we say so. If a product is not compatible with driving or the prospect of a doping test, we say so. If a customer's question goes beyond our expertise and scope, we refer them to healthcare professionals.

4. Relevance, or the art of useful content

For 321CBD, relevance is not an abstract notion. It's a concrete measure of the value we bring to our customers with every piece of information, every piece of advice, every product description we publish. If a piece of content doesn't bring something useful to our customers, if it doesn't answer a question they're asking or help them understand or use our CBD products, we consider it irrelevant.

The key to achieving relevance is to constantly listen to our customers. We're always interacting with them, whether it's through our customer service department, comments on product sheets, engagement on social networks or even direct discussions at the events we attend. We value every question, every comment, every feedback, as they are a valuable source of inspiration and editorial guidance for us.

By taking these interactions into account, we've developed an in-depth understanding of our customers' specific concerns, aspirations and needs. That's why every theme addressed in our blog posts and every point discussed in our product sheets are a direct reflection of these interactions. Our content is therefore not only based on in-depth research, but is also shaped by direct feedback from our customers.

In addition, we have adopted a proactive approach to ensuring the relevance of our content. In a field that evolves as rapidly as CBD, both scientifically and legally, information can become obsolete overnight. So we're always on the lookout for the latest studies and legislative developments on CBD and, more generally, hemp. This enables us to update our existing content and create new ones that respond to our customers' new questions and needs.

Ongoing training for our editorial team

With the aim of guaranteeing you quality, accurate and relevant content, we place great importance on the ongoing training of our editorial teams. We firmly believe that the competence of our writers is the foundation of the expertise we share with our customers and our community. This quest for editorial excellence is driven by 5 key points:

1. Initial training: every new member of our editorial team receives in-depth training covering all facets of CBD, cannabinoids and hemp. Our contributor develops a detailed understanding of what CBD is, the physiological mechanisms involved, the expected effects, potential side effects, different modes of consumption and legislation in France;
2. Up-to-date resources: we provide our editors with access to a constantly updated documentary database that includes scientific studies, health reports, press articles, trade journal papers and other relevant resources on CBD, cannabinoids and hemp. This editorial foundation enables them to draw on reliable data to produce solid, credible content;
3. Ongoing professional development: our editors are encouraged to participate in training courses, webinars and conferences related to CBD and its microenvironment. This enables them to broaden their knowledge, understand the latest advances in research and keep up to date with legislative developments;
4. Peer exchange and review: we have implemented a peer review process that promotes knowledge exchange and constructive feedback within the team. This approach enhances the quality of our content and ensures that all information shared is accurate and up-to-date;
5. Culture of curiosity: at 321CBD, we value curiosity and open-mindedness. Our editors are encouraged to ask questions, share their discoveries and discuss new trends and advances in CBD.

Biannual review of our content

In addition to the investment we make in the ongoing training of our editors, we have implemented a bi-annual auditing process of all our published content to ensure constant updating and maintain relevant, quality information for our community.

1. Information review: during the audit, every article, product description and guide is carefully reviewed to ensure that all information is up to date. We verify the facts mentioned, update statistical data, review references to scientific studies and update legislative information;
2. Content improvement: in addition to updating information, the audit is also an opportunity to improve existing content. Our editors look for ways to improve the clarity, relevance and value of each piece of content, whether by adding new information, clarifying complex points or supplementing articles with visuals, including infographics that summarize the key takeaways on each topic;
3. Reacting to customer feedback: the audit also enables us to take into account our customers' comments and suggestions. Whether it's a request for information on a new CBD product, a question about a recent study or a suggestion for a future blog post, we use this feedback to improve and enrich our content;
4. Search engine optimization: finally, the biannual audit also involves reviewing the search engine optimization (SEO) of our content. We make sure that our content is easy to find and accessible for anyone looking for reliable, quality information on CBD.

Read also:

Our CBD product selection process

Our evaluation process for CBD brands and CBD products